demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 mild to moderate
COVID-19 mild to moderate
antiandrogenic
progesterone Ghandehari

1 studies excluded by filtering options 0

7440 Cadegiani, 2021 013selection pending